ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Jan 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
February 2026
Nuclear Technology
December 2025
Fusion Science and Technology
November 2025
Latest News
Radium sources yield cancer-fighting Ac-225 in IAEA program
The International Atomic Energy Agency has reported that, to date, 14 countries have made 14 transfers of disused radium to be recycled for use in advanced cancer treatments under the agency’s Global Radium-226 Management Initiative. Through this initiative, which was launched in 2021, legacy radium-226 from decades-old medical and industrial sources is used to produce actinium-225 radiopharmaceuticals, which have shown effectiveness in the treatment of patients with breast and prostate cancer and certain other cancers.
P. Rodriguez-Fernandez, A. E. White, A. J. Creely, M. J. Greenwald, N. T. Howard, F. Sciortino, J. C. Wright
Fusion Science and Technology | Volume 74 | Number 1 | July-August 2018 | Pages 65-76
Technical Paper | doi.org/10.1080/15361055.2017.1396166
Articles are hosted by Taylor and Francis Online.
Understanding transport in magnetically confined plasmas is critical for developing predictive models for future devices such as ITER. Thanks to recent progress in simulation and theory, along with enhanced computational power and better diagnostic systems, direct and quantitative comparisons between experimental results and models is possible. However, validating transport models using additional constraints and accounting for experimental uncertainties still remains a formidable task. In this work, a new optimization framework is developed to address the issue of constrained validation of transport models. The Validation via Iterative Training of Active Learning Surrogates (VITALS) framework exploits surrogate-based strategies using Gaussian processes and sequential parameter updates to achieve the combination of plasma parameters that matches experimental transport measurements within diagnostic error bars. VITALS is successfully implemented to study L-mode plasmas in the Alcator C-Mod tokamak, and for the first time, additional measurable quantities, such as incremental diffusivity and fluctuation levels, are used during the validation process of the quasi-linear transport models TGLF-SAT1 and TGLF-SAT0. First results indicate that these machine-learning algorithms are very suitable and adaptable as a self-consistent, fast, and comprehensive validation methodology for plasma transport codes.